Catalog/Metabolic
Metabolic
Tirzepatide
Dual GIP / GLP-1 agonist
A dual incretin-receptor agonist studied for glucose handling and energy homeostasis.
Sequence
- Hydrophobic
- Polar
- Charged
39-residue dual agonist with fatty-diacid acylation
YXEGTFTSDYSIXLDSK(C20diacid)AQXAFVQWLIAGGPSSGAPPPS
- CAS
- 2023788-19-2
- Formula
- C225H348N48O68
- Mass (g/mol)
- 4813.45
- Half-life
- ~5 days
- Form
- Lyophilized
- Purity
- ≥98% HPLC
Mechanism
Co-activates GIP and GLP-1 receptors. Albumin binding via a C20 diacid extends half-life.
Research notes
Use low-binding tubes. Not a substitute for a prescribed product.
Lyophilized frozen, desiccated. Minimize freeze–thaw.
Typical reconstitution
Catalog convenience numbers — not a protocol. Vial 12 mg in 2 mL; default draw 2500 mcg.